Use of a Self-Care and Educational Mobile App to Improve Outcomes of Patients with Acute Decompensated Heart Failure during the COVID-19 Pandemic

Introduction

Heart failure (HF) is a global cause of significant morbidity as well as mortality, with an estimated prevalence of 1 million patients in the UK and 26 million patients worldwide¹. Patients with HF are at a high risk of readmission following index hospitalisation (25% within one month) and hospitalisations consume the bulk of costs (nearly 75%) related to HF care². Overall, the management of HF is estimated to cost around $30.7 billion in 2012 in the US and this is expected to balloon to $69.7 billion by 2030¹. Therefore, there is a pressing need for novel strategies aimed at improving HF care in a cost-efficient manner.

More than 50% of emergency hospital admissions for HF are associated with moderate or severe oedema³. As peripheral oedema usually accumulates over days or weeks and leads to weight gain, there is a clear opportunity to reduce emergency hospital admissions through patient self-management, better identification and control of fluid overload in the community.

We developed the Aintree Heart Failure Passport Mobile Application (App) for HF patient self-education and improved medication adherence. The aim of this study is to assess the effect of our mobile HF app upon self-care behaviour, medication adherence and 30 day re-hospitalisation during the ongoing Coronavirus disease-19 (COVID-19) pandemic.

Methods

This study was conducted in British university hospital from March 2020 to July 2021 during the ongoing COVID-19 pandemic. We assessed self-care behaviour (European Self-Care Behaviour Scale-9⁴) and medication adherence (MARS-5)⁵ at 2 weeks following attendance with ADHF amongst patients in the Ambulatory Acute HF Unit (AAHFU) who utilised a dedicated HF mobile Application (APP) (Aintree Heart Failure Passport Mobile APP). The AAHFU is a HF nurse delivered, consultant-led multidisciplinary day-case unit for out-patient management of ADHF with bolus intravenous diuretics.

The AHFP Mobile APP is available on both iOS (https://apps.apple.com/gb/app/aintree-heart-failure-passport/id1410856426) as well as Android platforms (https://play.google.com/store/apps/details?id=com.s3kdevelopers.aintreeheartfailurepassport&hl=en_GB&gl=US), free of charge. The APP incorporates the following patient education and self-care strategies -

• Traffic Light Based Tracker of patient symptoms and self-care advice (Figure)

• Daily weight monitoring and trigger for contacting HF team based on increased weight due to fluid overload

• Improved medication adherence through timed alerts/prompts as well as alerts about healthcare appointments

• Improved patient education regarding HF using videos

• Mood-check questionnaire to screen for anxiety or depression

• Download figure
• Open in new tab

Our study included patients from March 2020 to July 2021 who presented to the AAHFU with a primary diagnosis of acute decompensated heart failure (ADHF) based on the European Society of Cardiology definition of acute heart failure⁶. Other inclusion criteria included an ability to speak, understand and read English, possess a smartphone or have a carer who was agreeable to use the mobile App on their smartphone. Exclusion criteria consisted of cognitive impairment or those who died during the index admission.

Descriptive statistics were represented as continuous variables as means with standard deviations. Categorical variables were represented with percentages and analysed using Chi-squared test. Our study complied with the Declaration of Helsinki; the mobile App (funded by the hospital) and protocol were approved by the Institutional Board. The HF App study group included HF consultant cardiologists, HF specialist nurses, cardiology fellows, cardiac pharmacist, consultant pharmacologist and a HF expert patient.

Results

Outcomes of 148 out of 221 (67%) consecutive ADHF patients were analysed. 6% were excluded due to cognitive impairment, 20% did not have access to a smart phone and 7% were excluded due to being on the palliative care pathway. 45% of the recruited patients were women and the mean age of the cohort was 62 ± 6.1 years. 55% patients had HF with reduced ejection fraction (HFrEF), 34% had HF with preserved EF (HFpEF) and 11% had HF with mildly reduced EF (HFmrEF). The Charlson Co-morbidity Index⁷ in this cohort was moderate to severe (4.9 ± 1) and frailty (as assessed by the Rockwood Clinical Frailty Scale⁸ was mild (mean 4.7 ± 0.7).

HF self-care behaviour as assessed by the mean EHFSBs-9 was 19.1±6.7 indicating a high level of self-care behaviour. Similarly medication adherence as assessed by the mean MARS-5 score was also good (mean score 23.3±1). In total 16/148 (11%) patients were re-hospitalised within 30 days with HF (73 bed-days) compared to the annual hospital HF rehospitalisation rate which was 19%.

Discussion

Our study demonstrates that use of our HF mobile App can lead to improvements in several HF outcomes, especially high levels of self-care and high levels of medication adherence. It is likely that these in turn led to lower rates of 30-day HF re-hospitalisation. Whilst previous studies have shown the importance of nurse-led HF self-education on improved outcomes⁹, this is the first study reporting the results of HF patient education through use of a mobile phone APP, during the COVID-19 pandemic. These results are in keeping with a large review of 18 studies looking at a variety of HF Apps demonstrating trends towards a positive impact in patient care¹⁰.

A 2017 position statement from the American Health Association (AHA) advised that that self-care research has been held back by the perception by both physicians and patients that pharmacological interventions are more effective than lifestyle change despite evidence to the contrary and moving forward, a greater emphasis should be placed on self-care in evidence-based guidelines¹¹. The use of emerging health technologies such as smart devices to deliver health care services has been consistently on the rise over the past decade¹². The pervasive and ubiquitous nature of smart phones and the Apps that define them, create an opportunity in healthcare for closer integration of physicians and their patients. Smartphone Apps can create innovative solutions such as remote education and promotion of self-care strategies to help improve the outcomes of long term conditions such as HF. This is particularly relevant in the current era of the COVID-19 pandemic where mobile healthcare education can help reduce hospital visits and reduce the risk of further disease spread.

Conclusions

There is currently a rapidly growing requirement for digital technology interventions that can help promote heart failure self-care and thereby improve patient outcomes. Results from our pilot study suggest that use of a HF self-care mobile phone app (Aintree Heart Failure Passport App) in patients with ADHF, leads to high quality self-care behaviour, high levels of medication adherence and lower levels of 30-day HF re-hospitalisation. These results will need to be further validated in a randomised controlled trial.